Research Updates
Fenofibrate for Diabetic Retinopathy Progression
Victoria Adrian, PharmD, M Health Fairview
In the FIELD study, fenofibrate, a medication typically used for high triglycerides, was found to decrease the risk of diabetic neuropathy progression. Is this risk reduction statistically and clinically significant?
Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation
Carlos Nuñez Aguillon, PharmD, Minnesota Community Care | La Clinica
Guidelines and studies to support the use of anticoagulants such as apixaban, rivaroxaban, and warfarin used in atrial fibrillation (AF) to prevent ischemic stroke have excluded patients with cirrhosis. Are these treatments safe and effective for patients with AF and cirrhosis?
Therapeutic Thoughts
2024 Updates to GINA Strategy Report
Sakina Walji-Bandali, PharmD, Community-University Health Care Center (CUHCC)
The annual update of the GINA Strategy Report includes information essential to pharmacy practice. Changes have been made to diagnosis of asthma and assessment of asthma to determine initial choice of therapy. Additionally, the update contains discussion of asthma remission and emphasis on ensuring patients are up-to-date with recommended vaccines to prevent respiratory infections.
Guideline Updates in Lower Extremity Peripheral Artery Disease
Trista Betz, PharmD; CentraCare-Paynesville
The 2024 ACC/AHA Multisociety Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease provides updated recommendations on therapies to decrease cardiovascular risk and limb complications associated with this disease state.
The Vitamin D Dilemma: Comparing 2011 & 2024 Vitamin D Guidelines
Molly Malecha, PharmD, Hennepin Healthcare
The 2024 Endocrinology Society Clinical Practice Guideline on Vitamin D for the Prevention of Disease focuses on the use of empiric vitamin D screening and supplementation. This guideline both challenges and builds upon the 2011 guideline recommendations.
Miscellaneous News
Mobile Methadone: Increasing Accessibility to Opioid Use Disorder Treatment
Kaylee Deutsch, PharmD, Welia Health
With accessibility and convenience being key determinants of adherence to treatment, it is time that we consider bringing opioid use disorder treatment to the patients. New York and other states have established programs that do just that.
A Pharmacist Guide to Dispensing Medications for Muslim Patients
Salena Yang, PharmD, MPH, Goodrich Pharmacy
Teaser Summary: Pharmacists can support Muslim patients by ensuring that medications are permissible (halal) through an understanding of various unlawful (haram) medication ingredients and production methods.